Article Details

Sanofi, CytoReason join forces on AI-based asthma research

Retrieved on: 2021-06-24 16:18:45

Tags for this article:

Click the tags to see associated articles and topics

Sanofi, CytoReason join forces on AI-based asthma research. View article details on hiswai:

Excerpt

CytoReason, a company using artificial intelligence to create a computational disease model of the human body for drug development, has announced a ...

Article found on: www.outsourcing-pharma.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up